rsjwsgo

Property	Value
?:abstract	BACKGROUND: The fear of contagion during the coronavirus disease-2019 (COVID-19) pandemic may have potentially refrained patients with ST-segment elevation myocardial infarction (STEMI) from accessing the emergency system, with subsequent impact on mortality. OBJECTIVES: The ISACS-STEMI COVID-19 registry aims to estimate the true impact of the COVID-19 pandemic on the treatment and outcome of patients with STEMI treated by primary percutaneous coronary intervention (PPCI), with identification of “at-risk” patient cohorts for failure to present or delays to treatment. METHODS: This retrospective registry was performed in European high-volume PPCI centers and assessed patients with STEMI treated with PPPCI in March/April 2019 and 2020. Main outcomes are the incidences of PPCI, delayed treatment, and in-hospital mortality. RESULTS: A total of 6,609 patients underwent PPCI in 77 centers, located in 18 countries. In 2020, during the pandemic, there was a significant reduction in PPCI as compared with 2019 (incidence rate ratio: 0.811; 95% confidence interval: 0.78 to 0.84; p < 0.0001). The heterogeneity among centers was not related to the incidence of death due to COVID-19. A significant interaction was observed for patients with arterial hypertension, who were less frequently admitted in 2020 than in 2019. Furthermore, the pandemic was associated with a significant increase in door-to-balloon and total ischemia times, which may have contributed to the higher mortality during the pandemic. CONCLUSIONS: The COVID-19 pandemic had significant impact on the treatment of patients with STEMI, with a 19% reduction in PPCI procedures, especially among patients suffering from hypertension, and a longer delay to treatment, which may have contributed to the increased mortality during the pandemic. (Primary Angioplasty for STEMI During COVID-19 Pandemic [ISACS-STEMI COVID-19] Registry; NCT04412655).
is ?:annotates of	<https://research.tib.eu/covid-19/entity/5rsjwsgo_hasAnnotation_C0022116> <https://research.tib.eu/covid-19/entity/5rsjwsgo_hasAnnotation_C1825598>
?:creator	<https://research.tib.eu/covid-19/entity/De_Luca%2C_Giuseppe%3B_Verdoia%2C_Monica%3B_Cercek%2C_Miha%3B_Jensen%2C_Lisette_Okkels%3B_Vavlukis%2C_Marija%3B_Calmac%2C_Lucian%3B_Johnson%2C_Tom%3B_Ferrer%2C_Gerard_Rourai%3B_Ganyukov%2C_Vladimir%3B_Wojakowski%2C_Wojtek%3B_Kinnaird%2C_Tim%3B_van_Birgelen%2C_Clemens%3B_Cottin%2C_Yves%3B_IJsselmuiden%2C_Alexander%3B_Tuccillo%2C_Bernardo%3B_Versaci%2C_Francesco%3B_Royaards%2C_Kees-Jan%3B_Berg%2C_Jurrien_Ten%3B_Laine%2C_Mika%3B_Dirksen%2C_Maurits%3B_Siviglia%2C_Massimo%3B_Casella%2C_Gianni%3B_Kala%2C_Petr%3B_D%C3%ADez_Gil%2C_Jos%C3%A9_Luis%3B_Banning%2C_Adrian%3B_Becerra%2C_Victor%3B_De_Simone%2C_Ciro%3B_Santucci%2C_Andrea%3B_Carrillo%2C_Xavier%3B_Scoccia%2C_Alessandra%3B_Amoroso%2C_Giovanni%3B_Lux%2C_Arpad%3B_Kovarnik%2C_Tomas%3B_Davlouros%2C_Periklis%3B_Mehilli%2C_Julinda%3B_Gabrielli%2C_Gabriele%3B_Rios%2C_Xacobe_Flores%3B_Bakraceski%2C_Nikola%3B_Levesque%2C_S%C3%A9bastien%3B_Cirrincione%2C_Giuseppe%3B_Guiducci%2C_Vincenzo%3B_Kidawa%2C_Micha%C5%82%3B_Spedicato%2C_Leonardo%3B_Marinucci%2C_Lucia%3B_Ludman%2C_Peter%3B_Zilio%2C_Filippo%3B_Galasso%2C_Gennaro%3B_Fabris%2C_Enrico%3B_Menichelli%2C_Maurizio%3B_Garcia-Touchard%2C_Arturo%3B_Manzo%2C_Stephane%3B_Caiazzo%2C_Gianluca%3B_Moreu%2C_Jose%3B_For%C3%A9s%2C_Juan_Sanchis%3B_Donazzan%2C_Luca%3B_Vignali%2C_Luigi%3B_Teles%2C_Rui%3B_Benit%2C_Edouard%3B_Agostoni%2C_Pierfrancesco%3B_Bosa_Ojeda%2C_Francisco%3B_Lehtola%2C_Heidi%3B_Camacho-Freiere%2C_Santiago%3B_Kraaijeveld%2C_Adriaan%3B_Antti%2C_Ylitalo%3B_Boccalatte%2C_Marco%3B_Deharo%2C_Pierre%3B_Mart%C3%ADnez-Luengas%2C_I%C3%B1igo_Lozano%3B_Scheller%2C_Bruno%3B_Alexopoulos%2C_Dimitrios%3B_Moreno%2C_Raul%3B_Kedhi%2C_Elvin%3B_Uccello%2C_Giuseppe%3B_Faurie%2C_Benjamin%3B_Gutierrez_Barrios%2C_Alejandro%3B_Di_Uccio%2C_Fortunato_Scotto%3B_Wilbert%2C_Bor%3B_Smits%2C_Pieter%3B_Cortese%2C_Giulia142fd2d0b284e0a549fe3466c86d1c43>
?:doi	10.1016/j.jacc.2020.09.546
?:doi	<https://research.tib.eu/covid-19/entity/10.1016/j.jacc.2020.09.546>
?:journal	J_Am_Coll_Cardiol
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/ba4d6cbf530d481bf260a98e886378e29439aab1.json
?:pmc_json_files	document_parses/pmc_json/PMC7834750.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7834750>
?:pmid	<https://research.tib.eu/covid-19/entity/33183506.0>
?:pmid	33183506.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/ba4d6cbf530d481bf260a98e886378e29439aab1>
?:source	Elsevier; Medline; PMC
?:title	Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-17

Property

Value

?:abstract

BACKGROUND: The fear of contagion during the coronavirus disease-2019 (COVID-19) pandemic may have potentially refrained patients with ST-segment elevation myocardial infarction (STEMI) from accessing the emergency system, with subsequent impact on mortality. OBJECTIVES: The ISACS-STEMI COVID-19 registry aims to estimate the true impact of the COVID-19 pandemic on the treatment and outcome of patients with STEMI treated by primary percutaneous coronary intervention (PPCI), with identification of “at-risk” patient cohorts for failure to present or delays to treatment. METHODS: This retrospective registry was performed in European high-volume PPCI centers and assessed patients with STEMI treated with PPPCI in March/April 2019 and 2020. Main outcomes are the incidences of PPCI, delayed treatment, and in-hospital mortality. RESULTS: A total of 6,609 patients underwent PPCI in 77 centers, located in 18 countries. In 2020, during the pandemic, there was a significant reduction in PPCI as compared with 2019 (incidence rate ratio: 0.811; 95% confidence interval: 0.78 to 0.84; p < 0.0001). The heterogeneity among centers was not related to the incidence of death due to COVID-19. A significant interaction was observed for patients with arterial hypertension, who were less frequently admitted in 2020 than in 2019. Furthermore, the pandemic was associated with a significant increase in door-to-balloon and total ischemia times, which may have contributed to the higher mortality during the pandemic. CONCLUSIONS: The COVID-19 pandemic had significant impact on the treatment of patients with STEMI, with a 19% reduction in PPCI procedures, especially among patients suffering from hypertension, and a longer delay to treatment, which may have contributed to the increased mortality during the pandemic. (Primary Angioplasty for STEMI During COVID-19 Pandemic [ISACS-STEMI COVID-19] Registry; NCT04412655).

is ?:annotates of